HainsworthJD, Meric-BernstamF, SwantonC, et al. (2018) Targeted therapy for advanced solid tumors on the basis of molecular profiles: results from MyPathway, an open-label, phase IIa multiple basket study. J Clin Oncol, 36:536-542.
2.
HymanDM, Piha-PaulSA, WonH, et al. (2018) HER kinase inhibition in patients with HER2- and HER3-mutant cancers. Nature. 554:189-194.